ClinicalTrials.gg
Enrolling by invitationNCT07131800VOICEUpdated Aug 20, 2025

Objective and Perceptual Characteristics of the Voice After Endotracheal Intubation in Head and Neck Surgery

An observational study in Voice Disorder Due to Iatrogenic Factor, Endotracheal Intubation During Surgery and Thyroid Surgery, sponsored by Clinical Hospital Centre Zagreb. Enrolling by invitation at 1 site in Croatia. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-20.

Sponsored by Clinical Hospital Centre Zagreb · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
180
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Introduction: Possible consequences of endotracheal intubation are post-intubation voice changes.

Hypothesis: Endotracheal intubation during head and neck surgery is associated with objective and perceptual voice disorders.

Research objective: To investigate the short-term and long-term effects of endotracheal intubation on voice quality during head and neck surgery.

Material, subjects, methodology and research design: A prospective observational cohort study that will include patients undergoing surgery and endotracheal intubation lasting up to 3 hours. Adult patients divided into three groups will be included in the research: thyroid surgery, parotid gland surgery and abdominal surgery. Videostroboscopy, perceptual and objective acoustic voice analysis will be recorded before surgery, on the second postoperative day, two weeks and 1 month after surgery.

Expected scientific contribution of the proposed research: The scientific contribution would be an understanding of the risk factors and the connection of voice disorders after endotracheal intubation, as well as the ability to determine differences in this risk in patients undergoing different operations.

Read the detailed description

study protocol has been published and is attached below

02

Conditions studied

  • Voice Disorder Due to Iatrogenic Factor
  • Endotracheal Intubation During Surgery
  • Thyroid Surgery
  • Head and Neck Surgery

Browse trials for

Keywords

  • endotracheal intubation
  • surgery
  • head and neck
  • voice disorder
  • VHI
03

In context

Voice Disorders

77 studies on the registry are indexed under Voice Disorders; 17 are open to participants now.

This study's planned enrollment of 180 is above the median of 100 across 23 observational studies indexed under Voice Disorders.

Browse Voice Disorders studies →

Lead sponsor

Clinical Hospital Centre Zagreb is the lead sponsor of 32 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients scheduled for elective thyroid, head and neck surgery or abdominal surgery at the University Hospital Centre Zagreb. All eligible patients will be divided into three groups, as follows: patients scheduled for thyroid gland surgery; patients scheduled for some other type of head and neck operation that does not fall to exclusion criteria (parotidectomy, extirpation of congenital neck cyst, etc.); and control group including patients scheduled for operation other than the head and neck region. All operations will be performed by experienced operators with more than 100 annual procedures.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients scheduled for elective thyroid, head and neck surgery or abdominal surgery
  • 18 and 70 years,
  • normal preoperative voice status, and
  • normal laryngeal status.

Exclusion criteria

Exclusion Criteria:

  • \<18 years in the time of surgery
  • history of previous head and neck operation or radiotherapy
  • patients scheduled for head and neck operation that can alter acoustic characteristics of the voice (surgery of the nasal cavity, ear surgery, laryngeal surgery, jaw surgery).
  • Patients with preoperatively diagnosed pathologic vocal cord findings (nodules, polyps, vocal cord paralysis),
  • patients with postoperative injuries of the vocal cords, recurrent and superior laryngeal nerve,
  • patients with laryngopharyngeal reflux,
  • patients in whom postoperative evaluation of the voice cannot be performed due to uncooperativeness will also be excluded from the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
180 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • Patients undergoing thyroid surgery

    Patients undergoing scheduled thyroid surgery at the University Hospital Centre Zagreb under general endotracheal anesthesia without preoperative voice disorder regardless of the cause (previous operations or irradiation on the neck, and damage to the recurrent laryngeal nerve (RLN) during thyroidectomy).

  • Patients undergoing abdominal surgery

    Patients undergoing scheduled abdominal surgery at Day surgery of University Hospital Centre Zagreb under general anesthesia without preoperative voice disorder regardless of the cause (previous operations or irradiation on the neck, and damage to the recurrent laryngeal nerve (RLN) during thyroidectomy). This will include laparoscopic abdominal procedures and other minor abdominal procedures done in Day surgery, and will be control group for head and neck surgical procedures.

  • Patients undergoing other head and neck surgery besides thyroid

    Patients undergoing scheduled head and neck surgeries beside thyroid surgery at the University Hospital Centre Zagreb under general endotracheal anesthesia without preoperative voice disorder regardless of the cause (previous operations or irradiation on the neck, and damage to the recurrent laryngeal nerve (RLN) during thyroidectomy).

06

What researchers measure

Primary outcomes

  1. Subjective analysis of voice changes before and after endotracheal intubation for thyroid surgery, other head and neck surgery and abdominal surgery using Voice Handicap Index (VHI)

    The Voice Handicap Index (VHI) is one of the most frequently used self-assessment scales for voice disorders. The Croatian version was adapted and validated by Bonetti and Bonetti (2013), while Benšić et al. (2024) confirmed normative values for the Croatian language. The scale consists of 30 items divided into three subscales: \- Functional, emotional and physical component. Each item is rated on a 5-point Likert scale (0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Almost Always, 4 = Always), giving a total score from 0 to 120, with higher scores indicating greater perceived voice handicap. Participants will complete the VHI questionnaire at Baseline (within 7 days before surgery with endotracheal intubation) and at postoperative follow-up time points (Day 1, Week 2, and Week 4). The primary VHI outcome is the change in total score before and after surgery. Units of Measure: • Total score range: 0-120 Method of Administration: • Self-administered paper

    Time frame: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

  2. Subjective analysis of voice changes before and after endotracheal intubation for thyroid surgery, other head and neck surgery and abdominal surgery using GRBAS Scale (Perceptual Voice Evaluation)

    The perceptual voice assessment (GRBAS) will be conducted by two speech-language pathologists with several years of clinical experience. Each parameter-Grade, Roughness, Breathiness, Asthenia, and Strain-will be scored on a 4-point scale (0 = Normal, 1 = Slight, 2 = Moderate, 3 = Severe). The average of the two evaluators' scores will be taken, and in the case of significant discrepancies, a third evaluator will be consulted to reach consensus. Voice samples will be recorded at baseline and post-intervention at 4 time points total. The primary GRBAS outcome will be the change in the 'Grade' score; secondary analyses will include changes in R, B, A, and S. Units of Measure: • Ordinal scores (0-3) for each parameter

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

  3. Videostroboscopy Evaluation before and after surgery

    Videostroboscopy uses an endoscope containing a built-in video camera and a stroboscope, which records phonation while the vocal cords are being filmed. The recording captures the frequency of vocal cord vibrations during voice production and provides an apparently slow-motion view of these vibrations. In the stroboscopic video, the movements of the vocal cords are slowed down enough to precisely follow their motion. This technique allows detailed observation of the amplitude and symmetry of vibrations, as well as the phase of vocal cord closure during voice production. It facilitates diagnosis of numerous physical problems with the vocal cords, including paresis resulting from injury to the recurrent laryngeal nerve. Evaluations will be performed pre- and post-intervention using a standardized protocol. 2 experienced phoniatrists will independently review the recordings to identify possible pathology in vocal fold motion or structural damage. No formal scoring system will be applied.

    Time frame: Preoperative (within 7 days before surgery) and Postoperative day 1

  4. Objective Acoustic and Aerodynamic Voice Analysis - changes in fundamental frequency before and after surgery

    Objective voice evaluation will be performed using selected acoustic and aerodynamic measures. Voice assessment involves recording sustained phonation of the vowel /a/ in a sound-treated room using a calibrated digital recording system. The recordings will be acquired with a high-quality microphone positioned at a fixed distance of 30 cm from the participant's mouth, placed at a 45° angle. The sound signal will be analyzed using the LingWAVES SLP Suite Pro VPR software (WEVOSYS medical technology GmbH, Germany). This software converts the analog voice signal to digital form and processes it to extract relevant voice parameters. Parameters to be evaluated: • Fundamental frequency (F0) in Hz. Physiological reference values: • Fundamental frequency: Female: \~206 Hz, Male: \~120 Hz,

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

Secondary outcomes

  1. Objective Acoustic and Aerodynamic Voice Analysis - changes in Intensity before and after surgery

    Objective voice evaluation will be performed using selected acoustic and aerodynamic measures. Voice assessment involves recording sustained phonation of the vowel /a/ in a sound-treated room using a calibrated digital recording system. The recordings will be acquired with a high-quality microphone positioned at a fixed distance of 30 cm from the participant's mouth, placed at a 45° angle. The sound signal will be analyzed using the LingWAVES SLP Suite Pro VPR software (WEVOSYS medical technology GmbH, Germany). This software converts the analog voice signal to digital form and processes it to extract relevant voice parameters. Parameters to be evaluated: • Intensity (in dB) Physiological reference values: • Intensity: Female: 68-74 dB, Male: 68-76 dB

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

  2. Objective Acoustic and Aerodynamic Voice Analysis- changes in Jitter before and after surgery

    Objective voice evaluation will be performed using selected acoustic and aerodynamic measures. Voice assessment involves recording sustained phonation of the vowel /a/ in a sound-treated room using a calibrated digital recording system. The recordings will be acquired with a high-quality microphone positioned at a fixed distance of 30 cm from the participant's mouth, placed at a 45° angle. The sound signal will be analyzed using the LingWAVES SLP Suite Pro VPR software (WEVOSYS medical technology GmbH, Germany). This software converts the analog voice signal to digital form and processes it to extract relevant voice parameters. Parameters to be evaluated: • Jitter (%) Physiological reference values: • Jitter: 0-0.5%

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

  3. Objective Acoustic and Aerodynamic Voice Analysis- changes in shimmer before and after surgery

    Objective voice evaluation will be performed using selected acoustic and aerodynamic measures. Voice assessment involves recording sustained phonation of the vowel /a/ in a sound-treated room using a calibrated digital recording system. The recordings will be acquired with a high-quality microphone positioned at a fixed distance of 30 cm from the participant's mouth, placed at a 45° angle. The sound signal will be analyzed using the LingWAVES SLP Suite Pro VPR software (WEVOSYS medical technology GmbH, Germany). This software converts the analog voice signal to digital form and processes it to extract relevant voice parameters. Parameters to be evaluated: • Shimmer (%) Physiological reference values: • Shimmer: 0-5%

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

  4. Objective Acoustic and Aerodynamic Voice Analysis- changes in Maximum phonation time before and after surgery

    Objective voice evaluation will be performed using selected acoustic and aerodynamic measures. Voice assessment involves recording sustained phonation of the vowel /a/ in a sound-treated room using a calibrated digital recording system. The recordings will be acquired with a high-quality microphone positioned at a fixed distance of 30 cm from the participant's mouth, placed at a 45° angle. The sound signal will be analyzed using the LingWAVES SLP Suite Pro VPR software (WEVOSYS medical technology GmbH, Germany). This software converts the analog voice signal to digital form and processes it to extract relevant voice parameters. Parameters to be evaluated: • Maximum phonation time (MPT, in seconds) Physiological reference values: • Maximum phonation time: Female: 15-25 sec, Male: 25-35 sec

    Time frame: Time Points: Preoperative (within 7 days before surgery), Postoperative Day 1, Week 2, and Week 4

07

Study locations

1 site
08

References and documents

Publications

  • Simic I, Curic Radivojevic R, Slipac J, Prgomet D. VOICE CONDITION FOLLOWING SHORT-TERM ENDOTRACHEAL INTUBATION IN HEAD AND NECK SURGERY: STUDY PROTOCOL FOR CLINICAL TRIAL. Acta Clin Croat. 2023 Apr;62(Suppl1):49-54. doi: 10.20471/acc.2023.62.s1.06. PubMed 38746618 ↗

Individual participant data

Plan to share: No — At the moment, we do not know other logopedic laboratory being able to perform the same audiometric evaluation.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2024 (actual). Primary completion is estimated for Dec 2025, 15 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2025
First posted
Aug 20, 2025
StartActual
Sep 25, 2024
Primary completionEst.
Dec 31, 2025
CompletionEst.
Mar 30, 2026
Last update
Aug 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07131800
Lead sponsor
Clinical Hospital Centre Zagreb
Responsible party
Renata Curić Radivojević (Primarius; MD; PhD; FESAIC, Clinical Hospital Centre Zagreb) — Principal investigator
First posted
Aug 20, 2025
Start date
Sep 25, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
Aug 20, 2025

Study contacts

Ivana Šimić Prgomet, PhD, mag.logoped, Professor log.
principal investigator · Clinical Hospital Centre Zagreb
Drago Prgomet, MD; PhD, Professor
study director · Clinical Hospital Centre Zagreb
Renata Curić Radiovjević, Primarius
study chair · Clinical Hospital Centre Zagreb

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion